{
    "case_number": "CAC-UDRP-103825",
    "time_of_filling": "2021-05-25 09:30:30",
    "domain_names": [
        "boehringeringelhemimpetrebstes.com"
    ],
    "case_administrator": "Denisa Bilík (CAC) (Case admin)",
    "complainant": [
        "Boehringer Ingelheim Pharma GmbH & Co.KG"
    ],
    "complainant_representative": "Nameshield (Enora Millocheau)",
    "respondent": [
        "Whois Privacy Corp."
    ],
    "respondent_representative": null,
    "factual_background": "FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:\r\n\r\nThe Complainant (“Boehringer Ingelheim”) is a well-known research-driven German pharmaceutical group, which is active in various countries all over the world. The Complainant asserts that it currently has about 52.000 employees worldwide, and has amassed net sales amounting to 19.6 billion euros in 2020. The three business areas of Boehringer Ingelheim are human pharmaceuticals, animal health and biopharmaceuticals. \r\n\r\nThe Complainant has submitted evidence that it is the registered owner of the trademarks mentioned above under \"Identification of rights\".\r\n\r\nThe Complainant asserts that it owns the following domain name consisting of the trademark “Boehringer Ingelheim”: <www.boehringeringelheimpetrebates.com>. However, from the evidence submitted by the Complainant, it seems that a different company, ‘Boehringer Ingelheim Vetmedica Gmbh’, is the registered owner of this domain name, not the Complainant.\r\n\r\nThe disputed domain name was registered on May 17, 2021.\r\n\r\nThe Complainant has demonstrated that, at the time of filing its complaint, the disputed domain name refers to a parked webpage consisting of third-party commercial links.",
    "other_legal_proceedings": "The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.",
    "no_response_filed": "NO ADMINISTRATIVELY COMPLIANT RESPONSE HAS BEEN FILED.",
    "rights": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).",
    "no_rights_or_legitimate_interests": "The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).",
    "bad_faith": "The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).",
    "procedural_factors": "The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.",
    "decision": "Accepted",
    "panelists": [
        "Bart Van Besien"
    ],
    "date_of_panel_decision": "2021-06-26 00:00:00",
    "informal_english_translation": "The Complainant submitted evidence that it is the registered owner of the following trademarks:\r\n\r\n- International trademark registration n. 221544 “Boehringer-Ingelheim.” (word trademark), registered on July 2, 1959, and duly renewed, valid for classes 1, 2, 3, 4, 5, 6, 16, 17, 19, 29, 30, and 32 and valid in various countries; and\r\n- International trademark registration n. 568844 “Boehringer Ingelheim” (word trademark), registered on March 22, 1991, and duly renewed, valid for classes 1, 2, 3, 4, 5, 9, 10, 16, 30, and 31 and valid in various countries.",
    "decision_domains": {
        "BOEHRINGERINGELHEMIMPETREBSTES.COM": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}